Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does concurrent postoperative radiotherapy and chemotherapy in head and neck cancer improve patient outcome?

Nature Clinical Practice Oncology volume 1, pages 14–15 (2004)Cite this article

boxed-textCooper JS et al . (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. New Engl J Med 350: 1937–1944

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Peters LJ et al. (1993) Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 26: 3–11

    Article  CAS  Google Scholar 

  2. Bernier J et al. (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350: 1945–1952

    Article  CAS  Google Scholar 

  3. Trotti A and Bentzen SM (2004) The need for adverse effects reporting standards in oncology clinical trials. J Clin Oncol 22: 19–22

    Article  Google Scholar 

  4. Rosenthal DI et al. (2002) Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck 24: 115–126

    Article  Google Scholar 

  5. Rosenthal DI et al. (2004) Early postoperative paclitaxel followed by paclitaxel and cisplatin concurrent with radiation therapy (RT) (Phase II Trial RTOG H-0024) is well tolerated for patients with resected, high-risk squamous carcinoma of the head and neck (HNSCC) [abstract]. Proc Am Soc Ther Rad Oncol, in press

  6. Bonner JA et al. (2004) Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head or neck: a phase III study of high dose radiation therapy with or without cetuximab [abstract]. Proc Am Soc Clin Oncol 22: 5507

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by David Bruce, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. the Department of Radiation Oncology at The University of Texas M.D. Anderson Cancer Center, Associate Professor,

    Sue S Yom & David I Rosenthal

Authors
  1. Sue S Yom
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David I Rosenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David I Rosenthal.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yom, S., Rosenthal, D. Does concurrent postoperative radiotherapy and chemotherapy in head and neck cancer improve patient outcome?. Nat Rev Clin Oncol 1, 14–15 (2004). https://doi.org/10.1038/ncponc0009

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0009

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing